Report

Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Increasing Quality of Care - Workshop Summary

Released:: July 8, 2010
Type:: Workshop Summary
Topics:: Biomedical and Health Research, Substance Abuse and Mental Health, Diseases, Aging, Public Health, Quality and Patient Safety
Activity:: Forum on Neuroscience and Nervous System Disorders
Board:: Board on Health Sciences Policy

Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.

Mental, neurological, and substance use (MNS) disorders disrupt the lives of individuals and families across the world. The impact of these disorders—which range from epilepsy to depression to alcohol abuse—is especially significant in sub-Saharan Africa, where most of the world’s poorest countries are found. Millions of Africans in 47 countries suffer from some type of MNS disorder, and most cannot obtain treatment. Few psychiatrists or other mental health professionals work in sub-Saharan Africa, and those that do usually have private practices in urban centers. Health centers in rural areas, where the majority of the population lives, are few and far between, and drugs tend to be scarce and expensive. As such, many people with MNS disorders go undiagnosed and untreated; they and their families must bear the burden of their disease alone.

In August 2009, the Uganda National Academy of Sciences’ Forum on Health and Nutrition and the IOM’s Forum on Neuroscience and Neurological Disorders hosted a workshop in Kampla, Uganda, to discuss the state of care for MNS disorders in sub-Saharan Africa. More than 150 researchers, providers, patient advocates, and policy specialists attended. Speakers explored strategies to improve the quality and consistency of care, taking into account countries’ limited resources, infrastructure, and other realities. This document summarizes the workshop.

Reports of Interest

Living Well with Chronic Illness: A Call for Public Health Action Released: January 31, 2012
Barriers to Integrating Crisis Standards of Care Principles into... Released: January 23, 2012
Sex-Specific Reporting of Scientific Research - Workshop Summary Released: January 13, 2012

Strengthening a Workforce for Innovative Regulatory Science in... Released: December 21, 2011
Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity Released: December 15, 2011
Scientific Standards for Studies on Modified Risk Tobacco Products Released: December 14, 2011

Breast Cancer and the Environment: A Life Course Approach Released: December 7, 2011
Information Sharing and Collaboration: Applications to Integrated... Released: November 30, 2011
The Science and Applications of Synthetic and Systems Biology - Workshop... Released: November 23, 2011

back

Other Reports by this Activity

Displaying: 3 of 8 Reports

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System – A Workshop Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer’s, substance abuse, and traumatic brain injury. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The IOM’s Forum on Neuroscience and Nervous System Disorders held a workshop June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers.
Released: June 8, 2011
Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative - Workshop Summary Nearly 5.3 million Americans are living with Alzheimer’s disease, and 26.6 million people are affected worldwide. The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private partnership, provides a publicly available, international database of clinical and imaging data to foster research and collaboration on Alzheimer’s research worldwide. The IOM held a workshop on July 12, 2010, to explore opportunities to use information from and partnerships formed because of ADNI to continue to improve the understanding and treatment of Alzheimer’s disease.
Released: December 10, 2010
Sex Differences and Implications for Translational Neuroscience Research - Workshop Summary Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The IOM held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.
Released: December 10, 2010